Il trattamento anti-HIV che entra nella storia: basta una pillola al giorno
|
Gilead Sciences, Inc., colosso farmaceutico statunitense,
ha recentemente annunciato importanti risultati per una ; terapia
sperimentale contro l'HIV. |
Italiano — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.